Pfizer and Moderna will rake in $32 BILLION in COVID-19 vaccine sales in 2021 alone

Pfizer's vaccine, which passed a key FDA panel on Thursday, is expected to bring in $19 billion in revenue in 2021, on top of an estimated $975 million this year, according to Morgan Stanley.